GlassScriptPhysician profile
Erin C Werner
NPI 1730153115
$469.47
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $23.98 · 2021: $76.98 · 2022: $12.88 · 2023: $41.55 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $125.75 | 2024 | Trumatch |
| Abbvie INC. | $87.67 | 2019-2022 | |
| Allergan, INC. | $65.66 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.55 | 2023 | |
| Therapeuticsmd, INC. | $30.25 | 2019-2021 | |
| Duchesnay USA Incorporated | $18.76 | 2019 | |
| Evofem Biosciences, INC. | $18.74 | 2021 | |
| Merck Sharp & Dohme LLC | $16.36 | 2019 | |
| Astellas Pharma US INC | $13.92 | 2019 | |
| Daiichi Sankyo INC. | $13.85 | 2019 | |
| Avion Pharmaceuticals | $12.99 | 2019 | |
| Organon LLC | $12.20 | 2024 | |
| Roche Diagnostics Corporation | $11.77 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Werner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.